Business
Practice ManagementMalpractice ConsultHealth Law & Policy
Media
Case-Based Peer PerspectivesInvestigator Perspectives Medical World NewsPodcastsUrology Medical PerspectivesUTv VideosPeer ExchangeSpecial ReportVirtual Tumor BoardClinical Forum InsightsInsightsMedcastPeers & Perspectives
Conferences
Conference ListingConference Previews Conference Recaps
Publications
Urology Times JournalEditorial Advisory BoardUrologists in Cancer CareSupplements and Featured PublicationsClinical Forums Recaps
More
CME/CE
Resources
Begin Your Journey: Tackling BurnoutSponsored MediaLive EventsInteractive ToolsJob BoardPartnersSponsored ResourcesTreatment Landscape Evolutions

Subscribe

  • Business
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Benign Conditions
  • Benign Prostatic Hyperplasia
  • Bladder Cancer
  • Female Urology
  • Genitourinary Cancers
  • Genomic Testing
  • Hormone Therapy
  • Kidney Cancer
  • Kidney Stones
    • Challenging Anatomy
  • Men's Health
  • Next-Generation Imaging
  • OAB and Incontinence
    • Voiding Dysfunction
  • Pediatrics
  • Prostate Cancer
    • Controveries in Urologic Cancer
    • Drug Therapy
  • Sexual Dysfunction
  • UTUC
  • Urologic Surgery
    • Cosmetic Surgery
Spotlight -
Peer Exchange|
Peers and Perspectives|
Case-Based Peer Perspectives|
Urology Times Journal
Advertisement

Jason M. Broderick and Cheryl Guttman Krader, BS, Pharm

Advertisement

Articles by Jason M. Broderick and Cheryl Guttman Krader, BS, Pharm

PINNACLE trial aims to confirm pilot success with BPH drug-coated balloon catheter

ByJason M. Broderick and Cheryl Guttman Krader, BS, Pharm
August 3rd 2020

The drug-coated balloon catheter system is being compared with a sham device in a double-blinded randomized trial.

Advertisement

Latest Updated Articles

  • PINNACLE trial aims to confirm pilot success with BPH drug-coated balloon catheter
    PINNACLE trial aims to confirm pilot success with BPH drug-coated balloon catheter

    Published: August 3rd 2020 | Updated:



Advertisement
Advertisement

Trending on Urology Times

1

Trial to compare 225Ac-PSMA-617 vs 177Lu-PSMA-617 for oligorecurrent prostate cancer

2

Farah Rahman, MD, on monitoring resident wellness using biofeedback

3

Veda Giri, MD, on patient-reported outcomes with prostate cancer genetic testing

4

Pearls & Perspectives: Innovation and Evolving Pathways in Female Pelvic Medicine, with Raveen Syan, MD, FPMRS

5

John Sfakianos, MD, on dual immune checkpoint inhibition in NMIBC

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Job Board
  • Terms and Conditions
  • Privacy
  • Do not sell my Personnal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us